hotspot -WSS

hotspot

author：entertainment 2025-09-30 19:26:51 - browse：559

Duchenne muscular dystrophy Histopathology — Duchenne muscular dystrophy histopathology. Dr. Edwin P. Ewing, Jr./CDC

Japanese drugmaker Nippon Shinyaku said on Monday that its Duchenne muscular dystrophy drug, Viltepso, part of a controversial class of treatments for the rare disease, had failed to reach its primary endpoint in a placebo-controlled confirmatory trial.

Children who received the drug could stand up faster from the floor at the end of the study, but so could children who received a placebo. There was no statistically significant difference between the groups.

Although Nippon did not release detailed data, the failure is notable because Viltepso belongs to a contentious class of drugs called exon-skippers. Duchenne is caused by mutations in a muscle-supporting gene called dystrophin. These drugs are designed to increase the amount of dystrophin protein that patients with specific mutations produce. But the drugs only lead to slight increases in protein levels, and their clinical benefits have never been proven in a large, placebo-controlled study.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Blood tests recalled over risk of missed heart attack diagnosis

WSS

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Chimpanzees, like humans and whales, get menopause: Study

Medtronic CEO on promising devices for diabetes, hypertension

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

Congress likely to miss an opportunity to fix drug shortages issue

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

In Memoriam: Notable people who died in 2023

Biden's order seeks to regulate AI risk without stifling innovation

Malaria cases in Florida and Texas: Here’s what you need to know

Celiac disease study examines precisely how gluten triggers injury

Drug repurposing or repositioning? The language matters

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Cancer drug shortages should be causing more outrage

Celiac disease study examines precisely how gluten triggers injury

Malaria cases in Florida and Texas: Here’s what you need to know

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

focus

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

FDA has safety concerns on CRISPR

Federal judge rules Oregon’s tough new gun law is constitutional

Grail faces three suits alleging harassment, retaliation

CDC recommends rationing of RSV shot due to shortages

Everything to know for the next Powerball drawing as jackpot hits $1 billion

entertainment

leisure time

entertainment

hotspot